Financials Origin Therapeutics Holdings Inc. Canadian Securities Exchange

Equities

ORIG

CA68622H1073

Investment Management & Fund Operators

End-of-day quote Canadian Securities Exchange 18:00:00 2024-02-04 EST 5-day change 1st Jan Change
0.115 CAD -11.54% Intraday chart for Origin Therapeutics Holdings Inc. -14.81% -39.47%

Income Statement Evolution (Annual data)

Fiscal Period: September 2023
Net sales -
EBITDA -
EBIT 1 -2.202
Operating Margin -
Earnings before Tax (EBT) 1 -9.46
Net income 1 -9.46
Net margin -
EPS 2 -0.3040
Free Cash Flow -
FCF margin -
FCF Conversion (EBITDA) -
FCF Conversion (Net income) -
Dividend per Share -
Announcement Date 24-01-22
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2023
Net Debt 1 -
Net Cash position 1 3.77
Leverage (Debt/EBITDA) -
Free Cash Flow -
ROE (net income / shareholders' equity) -
ROA (Net income/ Total Assets) -
Assets 1 -
Book Value Per Share 2 0.0300
Cash Flow per Share 2 0.0500
Capex -
Capex / Sales -
Announcement Date 24-01-22
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SPLY Stock
  4. ORIG Stock
  5. Financials Origin Therapeutics Holdings Inc.